Back to search results

MedSMA℞T Mobile for Opioid Safety

This study is testing a new smartphone app called MedSMA℞T Mobile. It's designed to help parents and their teenage children (ages 12-18) learn about opioid safety and prevent misuse. The study wants to see if using MedSMA℞T Mobile, in addition to regular opioid counseling, can improve people's knowledge and attitudes about opioid misuse. You might be able to join if you are an adult who gets an opioid prescription from an emergency department, have a teenager (12-18) living at home, and speak English. The study is currently unclear on its recruitment status.

Study design
This is an interventional study with a planned enrollment of 244 participants. The phase of the study is not specified.
What's involved
You would receive opioid counseling, join an online meeting to test the smartphone app, report demographic information, complete surveys about opioids, and create a family medication safety plan. You would also complete surveys after 3, 6, and 9 months.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 9 months, with surveys completed at baseline, 3, 6, and 9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06848504

MedSMA℞T Mobile ED

Not Yet Recruiting
NAAges 12+Interventional
Olufunmilola Abraham
~244 participants
Updated 2026-03-17 on ClinicalTrials.gov
What's tested:MedSMA℞T Mobile

At a glance

Recruiting sites
0 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Adolescent Opioid Safety and Learning (AOSL) scale score over 9 month study
Measured over Baseline, 3, 6, and 9 months.

Conditions

Opiate-Related Disorders
Opiate Use Disorder
Opioid

Explore related trials

Opioid Use Disorder

Where it's being run

3 sites across 2 states
Wisconsin2
Illinois1

Study leadership

  • Olufunmilola Abraham, PhD · PRINCIPAL_INVESTIGATOR · University of Kentucky College of Pharmacy

Who to contact

Joseph Strong
[email protected]
859-562-2766
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults who receive an opioid prescription from a study Emergency Department, AND
who report having an adolescent, aged 12-18, living at home, AND
who speak and understand English
Each participant must have the ability to provide informed consent

Exclusion

Adults who do not receive an opioid prescription from a study Emergency Department AND/OR
who do not have an adolescent, aged 12-18, living at home, AND/OR
who do not speak or understand English
Adults and/or adolescents who do not have the ability to provide informed consent

What this trial measures

  • Change in Adolescent Opioid Safety and Learning (AOSL) scale score over 9 month studyBaseline, 3, 6, and 9 months.

    The fourth factor of the Adolescent Opioid Safety and Learning (AOSL) scale, Opioid Harm, measures understanding of negative social and professional effects of opioid misuse. Scores range from 3-15, where 3 indicates the lowest level of overall opioid harm awareness and 15 is the highest level.